Corteva (CTVA) Stock Forecast & Price Target

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

• The Board of Directors recently approved the separation of the company's seed operating segment into an independent, publicly traded company named Vylor Inc., a strategic move that could unlock value by allowing each business to focus on its specific growth drivers and capital allocation needs.
• Corteva, Inc. is currently trading at $82.61, which is below the consensus price target of $91.50 held by fourteen analysts who have issued Buy ratings, suggesting that the stock may be undervalued relative to its expected future performance.
• The company recently announced a joint venture with Globachem to develop new crop-protection solutions, a partnership that is expected to expand the product pipeline and support longer-term growth in agricultural inputs.
• KeyCorp estimates that Corteva, Inc. will earn $4.00 per share in fiscal 2027 and $4.20 in fiscal 2028, which are figures above the current-year consensus estimate of $3.72, indicating a constructive long-term earnings outlook and expected growth following 2026.
• Several institutional investors, including Squarepoint Ops LLC and Brighton Jones LLC, have significantly increased their stakes in the company during recent quarters, with Squarepoint Ops LLC boosting its position by 77.8% in the second quarter, signaling strong institutional confidence in the stock.